A TLR7 Agonist Inhibits Bronchoconstriction In Vivo and In Vitro.

被引：0
作者：
Kaufman, E. H. [1 ]
Fryer, A. D. [1 ]
Jacoby, D. B. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2811
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Mechanism of Action of Inhibition of Allergic Immune Responses by a Novel Antedrug TLR7 Agonist
    Matsui, Hiroyuki
    Tomizawa, Hideyuki
    Eiho, Kazuo
    Kashiwazaki, Yasuo
    Edwards, Susan
    Biffen, Mark
    Bell, John P.
    Bahl, Ashwani
    Leishman, Andrew J.
    Murray, Clare M.
    Takaku, Haruo
    Ueda, Yutaka
    JOURNAL OF IMMUNOLOGY, 2012, 189 (11) : 5194 - 5205
  • [42] Conjugate of ibrutinib with a TLR7 agonist suppresses melanoma progression and enhances antitumor immunity
    Ren, Sumei
    Wang, Xiaodong
    Jin, Guangyi
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (01): : 166 - 179
  • [43] Different innate immune profiles by astrocytes and microglia following TLR7 and/or TLR9 agonist stimulation
    Butchi, Niranjan B.
    Du, Min
    Karin, Peterson
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [44] Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: Comparison of multiple TLR7 and/or TLR8 agonists
    Butchi, Niranjan B.
    Pourciau, Susan
    Du, Min
    Morgan, Tim W.
    Peterson, Karin E.
    JOURNAL OF IMMUNOLOGY, 2008, 180 (11) : 7604 - 7612
  • [45] A dual and conflicting role for imiquimod in inflammation: A TLR7 agonist and a cAMP phosphodiesterase inhibitor
    Ernst, Orna
    Failayev, Hila
    Athamna, Muhammad
    He, Haoming
    Tsfadia, Yossi
    Zor, Tsaffrir
    BIOCHEMICAL PHARMACOLOGY, 2020, 182
  • [46] High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation
    Gadd, Adam J. R.
    Castelletto, Valeria
    Kabova, Elena
    Shankland, Kenneth
    Perrie, Yvonne
    Hamley, Ian
    Cobb, Alexander J. A.
    Greco, F.
    Edwards, Alexander D.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 123 : 268 - 276
  • [47] TLR7 agonist modulation of postasphyxial neurophysiological and cardiovascular adaptations in preterm fetal sheep
    Cho, Kenta H. T.
    Fraser, Mhoyra
    Wassink, Guido
    Dhillon, Simerdeep J.
    Davidson, Joanne O.
    Dean, Justin M.
    Gunn, Alistair J.
    Bennet, Laura
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2020, 318 (02) : R369 - R378
  • [48] Isatoribine -: Anti-hepatitis C virus drug TLR7 receptor agonist
    Davies, SL
    Castañer, J
    Fernández, D
    DRUGS OF THE FUTURE, 2005, 30 (09) : 886 - 891
  • [49] Immunogenicity and safety of a transdermal multi-peptide vaccine with and without a TLR7 agonist
    Olson, Walter C.
    Woodson, Elizabeth
    Chianese-Bullock, Kimberly
    Murphy, Cheryl F.
    Coleman, Elizabeth
    Galeassi, Nadejda V.
    Nguyen, Phuong V.
    Neese, Patrice Y.
    Nail, Carmel J.
    Slingluff, Craig L.
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 653 - 654
  • [50] Gastrointestinal/liver-targeted TLR7 agonist for treatment of colorectal and liver cancers
    Miller, Andrew T.
    Rodrigo, Evelyn
    Corpuz, Manny
    Plouffe, David
    Wu, Tom Y-H
    CANCER RESEARCH, 2020, 80 (16)
12345